CRISPR Therapeutics AG (CRSP)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 53.55 |
| Open | 54.09 |
| Bid | 51.08 x 300 |
| Ask | 51.19 x 300 |
| Day's range | 51.02 - 54.89 |
| 52-week range | 37.55 - 91.10 |
| Volume | |
| Avg. volume | 1,694,396 |
| Market cap | 4.552B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.94 |
| Earnings date | 08 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 84.42 |
- GuruFocus.com
CRISPR Therapeutics AG Reports Q1 2024 Earnings: Misses Analyst Net Income Forecast
Detailed Overview of Financial Performance and Strategic Initiatives
Simply Wall St.We're Interested To See How CRISPR Therapeutics (NASDAQ:CRSP) Uses Its Cash Hoard To Grow
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
ZacksCRISPR's (CRSP) Q1 Loss Narrower-Than-Expected, Sales Miss
CRISPR Therapeutics (CRSP) reports mixed earnings results for first-quarter 2024. Management claims that the commercial launch for the first ever CRISPR-based gene therapy is progressing well.
© 2024 Yahoo. All rights reserved.